Fortress Biotech, Inc. FBIO
2.28
0.00
0.00%
as of 25 Sep
- Market cap
- $76.0M
- P/E
- 0.7×
Follow FBIO
Growth Flags
show if company had growth for consecutive years
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
6.79 | 9.84 | 1.39 | 3.84 | 5.01 | 2.97 | 0.76 | 0.26 | 0.73 | 1.61 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
(6.23) | (8.13) | (1.69) | (5.62) | (11.15) | (5.28) | (1.21) | (0.62) | (3.27) | (8.14) |
P/B ratio |
1.35 | 1.41 | 1.89 | 1.94 | 1.16 | 0.90 | 1.15 | 13.77 | 0.00 | 1.64 |
Price to Tangible BV |
2.39 | 1.42 | 2.04 | 2.16 | 1.25 | 0.96 | 2.53 | 0.00 | 0.00 | 2.95 |
EV/Sales |
2.82 | 5.10 | 0.55 | 2.60 | 1.24 | (0.79) | (0.32) | 0.13 | 0.90 | 1.25 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.30 | 0.13 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(1.01) | (1.08) | (0.15) | (1.00) | (0.68) | 0.46 | 0.14 | (0.09) | (0.65) | (1.20) |
EV/FCF |
(0.82) | (1.03) | (0.14) | (0.90) | (0.62) | 0.41 | 0.12 | (0.07) | (0.44) | (0.75) |
Quick Ratio |
1.77 | 1.95 | 1.63 | 3.32 | 4.99 | 3.26 | 1.62 | 1.13 | 0.95 | 2.20 |
Current Ratio |
1.94 | 2.56 | 2.00 | 3.43 | 5.14 | 3.43 | 1.80 | 1.38 | 1.27 | 2.49 |
Net Debt/EBITDA |
1.01 | 0.80 | 0.03 | 0.44 | 2.01 | 1.45 | 0.43 | 0.15 | (0.01) | 0.43 |
Debt/Assets |
16.53% | 25.41% | 56.39% | 40.38% | 19.85% | 11.95% | 32.65% | 36.33% | 40.19% | 28.25% |
Debt/Equity |
0.34 | 0.52 | 4.03 | 1.26 | 0.34 | 0.21 | 1.92 | 38.35 | (35.26) | 0.84 |
Asset Turnover |
0.11 | 0.08 | 0.14 | 0.20 | 0.16 | 0.19 | 0.22 | 0.37 | 0.37 | 0.38 |
Operating CF/Net income |
0.83 | 1.22 | 1.17 | 2.38 | 1.80 | 1.80 | 1.90 | 1.87 | 1.43 | 34.95 |
Capex/Depreciation |
(3.81) | (0.91) | (2.09) | (1.18) | (0.65) | (1.53) | (0.26) | (0.19) | (1.60) | 0.15 |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (65.89%) | (65.74%) | (120.00%) | (86.61%) | (34.52%) | (30.60%) | (68.58%) | (266.13%) | 177,428.57% | (6.22%) | |
| (38.08%) | (32.10%) | (43.49%) | (21.75%) | (16.62%) | (17.73%) | (27.39%) | (29.74%) | (35.86%) | (1.14%) | |
ROIC |
(210.59%) | (107.83%) | (464.85%) | (255.54%) | (197.50%) | 0.00% | 0.00% | 0.00% | 0.00% | (124.61%) |
Return on Tangible Assets |
(91.15%) | (56.26%) | (124.46%) | (32.47%) | (20.56%) | (24.84%) | (81.74%) | (177.81%) | (251.39%) | (2.46%) |
Average Days of Receivables |
192.44 | 177.28 | 103.10 | 143.53 | 197.49 | 126.23 | 136.60 | 66.46 | 65.83 | 172.75 |
Research and Development Expense of Revenue |
213.19% | 304.35% | 325.06% | 222.03% | 140.59% | 187.33% | 178.07% | 125.51% | 98.62% | 18.81% |
Selling, General and Administrative Expense of Revenue |
208.24% | 295.14% | 198.54% | 151.76% | 134.14% | 126.24% | 150.05% | 107.65% | 152.11% | 152.38% |
Intangible Assets out of Total Assets |
0.21 | 0.00 | 0.01 | 0.03 | 0.04 | 0.03 | 0.09 | 0.12 | 0.22 | 0.15 |
Share Based Compensation of Revenue |
83.80% | 85.21% | 67.38% | 43.45% | 32.53% | 29.52% | 30.35% | 21.93% | 56.75% | 45.43% |
Graham Net Nets |
0.20 | 0.34 | (0.27) | 0.02 | 0.57 | 0.86 | (0.24) | (2.24) | (1.32) | 0.00 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.36 | 0.00 |
Earnings Yield |
(48.90%) | (39.54%) | (263.32%) | (27.22%) | (20.18%) | (31.58%) | (149.16%) | (338.45%) | (154.23%) | (2.19%) |
Free Cash Flow Yield |
(50.31%) | (50.38%) | (289.35%) | (75.03%) | (40.33%) | (65.13%) | (350.93%) | (690.76%) | (278.92%) | (102.44%) |
Revenue per Share |
6.18 | 6.21 | 9.27 | 10.04 | 9.49 | 12.62 | 12.78 | 10.42 | 2.78 | 2.27 |
Operating CF per Share |
(17.19) | (29.26) | (34.10) | (26.02) | (17.42) | (21.39) | (30.28) | (15.81) | (3.86) | (2.36) |
Capex per Share |
(3.94) | (1.44) | (3.23) | (2.57) | (1.49) | (3.00) | (0.49) | (0.26) | (0.72) | 0.04 |
Free Cash Flow per Share |
(21.13) | (30.70) | (37.33) | (28.60) | (18.92) | (24.39) | (30.77) | (16.07) | (4.58) | (2.32) |
Cash per Share |
34.40 | 47.13 | 28.67 | 37.50 | 48.59 | 56.11 | 30.09 | 9.98 | 2.76 | 2.85 |
Shareholders Equity per Share |
31.13 | 43.37 | 6.81 | 19.88 | 41.02 | 41.45 | 8.44 | 0.20 | (0.08) | 2.23 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
31.13 | 43.37 | 6.81 | 19.88 | 41.02 | 41.45 | 8.44 | 0.20 | (0.08) | 2.23 |
Free Cash Flow |
(56.32) | (85.32) | (108.20) | (104.36) | (90.85) | (132.89) | (182.33) | (130.32) | (95.19) | (64.61) |
Working Capital |
53.07 | 111.74 | 55.59 | 110.64 | 214.39 | 245.42 | 102.72 | 32.11 | 18.97 | 74.10 |
Capital Expenditures |
(10.50) | (4.01) | (9.36) | (9.39) | (7.16) | (16.35) | (2.93) | (2.10) | (15.00) | 1.17 |
Net Current Asset Value |
21.87 | 57.73 | (10.04) | 2.36 | 129.74 | 175.84 | (13.84) | (48.92) | (55.50) | 0.48 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.29 | 0.12 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.64 | 0.23 | 0.35 | 0.26 | 0.16 | 0.24 | 0.04 | 0.02 | 0.26 | (0.02) |
Net Profit Margin |
(334.31%) | (387.80%) | (313.02%) | (109.09%) | (102.03%) | (94.06%) | (124.91%) | (81.25%) | (96.91%) | (2.97%) |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.37 | 0.62 | 0.37 | 0.64 | 0.92 | 0.71 | 0.88 | 1.71 | 2.87 | 3.18 |
Cash ROIC |
(26.22%) | (28.16%) | (60.80%) | (35.70%) | (19.25%) | (22.73%) | (59.32%) | (93.97%) | (73.47%) | (35.21%) |
Accounts Receivable Turnover |
3.73 | 2.02 | 3.37 | 3.33 | 2.33 | 2.84 | 2.91 | 3.86 | 4.47 | 3.14 |
Accounts Payable Turnover |
0.05 | 0.14 | 0.20 | 0.30 | 0.36 | 0.47 | 0.33 | 0.27 | 0.30 | 0.37 |
Inventory Turnover |
4.22 | 19.56 | 14.43 | 13.72 | 12.91 | 5.70 | 2.56 | 1.88 | 1.69 | 1.74 |
Average Days of Payables |
11,224.91 | 2,757.36 | 2,030.12 | 1,228.60 | 1,135.19 | 1,031.38 | 1,155.74 | 1,172.85 | 1,145.07 | 822.05 |
Days of Inventory on Hand |
93.79 | 17.06 | 40.40 | 29.70 | 35.11 | 112.19 | 167.93 | 162.72 | 252.28 | 167.88 |
Average Receivables |
4.42 | 8.53 | 7.98 | 11.00 | 19.54 | 24.23 | 26.07 | 21.87 | 12.90 | 20.17 |
Average Payables |
17.37 | 25.96 | 30.85 | 34.76 | 40.42 | 68.02 | 94.05 | 85.50 | 69.53 | 56.31 |
Average Inventory |
0.19 | 0.19 | 0.42 | 0.77 | 1.13 | 5.63 | 12.01 | 12.18 | 12.32 | 12.03 |
Average Assets |
144.67 | 208.34 | 193.47 | 183.71 | 279.92 | 364.96 | 345.40 | 230.91 | 155.87 | 164.89 |
Average Common Equity |
83.62 | 101.73 | 70.12 | 46.14 | 134.76 | 211.44 | 137.95 | 25.80 | (0.03) | 30.27 |
Columns are period end dates